Re:UBiome received $83M in Series C financing
by timr on Friday September 21, 2018 @08:49PM
(#18043829)
I'd put Denali in the "actually does science" category, though. Certainly more than uBiome. They do have a drug in clinical trials, after all.
There is just a ton of money right now.
Even for companies like uBiome whose business strategy is “we’ll sequence your microbiome and <waves hands around furiously>”